{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:10:07Z","timestamp":1791112207539,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1006\/nbdi.2000.0375","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T19:46:43Z","timestamp":1032378403000},"page":"343-350","source":"Crossref","is-referenced-by-count":54,"title":["Upregulation of Striatal Preproenkephalin Gene Expression Occurs before the Appearance of Parkinsonian Signs in 1-Methyl-4-phenyl- 1,2,3,6-tetrahydropyridine Monkeys"],"prefix":"10.1006","volume":"8","author":[{"given":"Erwan","family":"Bezard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Ravenscroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian E.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Crossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Brotchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/nbdi.2000.0375_RF1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-F","article-title":"Parkinson's disease: Pathophysiology","volume":"337","author":"Agid","year":"1991","journal-title":"Lancet"},{"key":"10.1006\/nbdi.2000.0375_RF2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: Neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1006\/nbdi.2000.0375_RF3","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00001756-199410270-00037","article-title":"Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys","volume":"5","author":"Asselin","year":"1994","journal-title":"Neuroreport"},{"key":"10.1006\/nbdi.2000.0375_RF4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/377424a0","article-title":"Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors","volume":"377","author":"Baik","year":"1995","journal-title":"Nature"},{"key":"10.1006\/nbdi.2000.0375_RF5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0306-4522(97)00226-1","article-title":"Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental parkinsonism","volume":"81","author":"Bezard","year":"1997","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2000.0375_RF6","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1046\/j.1460-9568.1999.00627.x","article-title":"Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms","volume":"11","author":"Bezard","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1006\/nbdi.2000.0375_RF7","series-title":"The Basal Ganglia VI","article-title":"Evolution of the multiunit activity of basal ganglia in the course of a dynamic experimental parkinsonism","author":"Bezard","year":"2000"},{"key":"10.1006\/nbdi.2000.0375_RF8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00001756-199701200-00012","article-title":"Presymptomatic revelation of experimental parkinsonism","volume":"8","author":"Bezard","year":"1997","journal-title":"Neuroreport"},{"key":"10.1006\/nbdi.2000.0375_RF9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-8993(97)00531-3","article-title":"A chronic MPTP model reproducing the slow evolution of Parkinson's disease: Evolution of motor symptoms in the monkey","volume":"766","author":"Bezard","year":"1997","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0375_RF10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1006\/nbdi.2000.0375_RF11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/exnr.1997.6771","article-title":"Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat","volume":"150","author":"Duty","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.2000.0375_RF12","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klin. Wochenschr."},{"key":"10.1006\/nbdi.2000.0375_RF13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(91)90933-M","article-title":"Terminal excitability of the corticostriatal pathway. I. Regulation by dopamine receptor stimulation","volume":"551","author":"Garcia-Munoz","year":"1991","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0375_RF14","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1006\/nbdi.2000.0375_RF15","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1471-4159.1991.tb02027.x","article-title":"Preproenkephalin mRNA and methionine-enkephalin increase in mouse striatum after 1-methyl-1,2,3,6-tetrahydropyridine treatment","volume":"56","author":"Gudehithlu","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2000.0375_RF16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1998.6996","article-title":"Effect of repeated l-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat","volume":"155","author":"Henry","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.2000.0375_RF17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0306-4522(95)00120-8","article-title":"Effects of l-Dopa on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum","volume":"68","author":"Herrero","year":"1995","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2000.0375_RF18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.47.1.219","article-title":"Consequence of nigrostriatal denervation and l-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum","volume":"47","author":"Herrero","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/nbdi.2000.0375_RF19","first-page":"1654","article-title":"A new chronic MPTP model: Validation in monkey and mouse","volume":"23","author":"Imbert","year":"1997","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1006\/nbdi.2000.0375_RF20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.410320608","article-title":"Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine","volume":"32","author":"Jenkins","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2000.0375_RF21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0306-4522(96)00409-5","article-title":"Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states","volume":"76","author":"Levy","year":"1997","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2000.0375_RF22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1460-9568.1995.tb01110.x","article-title":"Effects of nigrostriatal denervation and L-Dopa therapy on the GABAergic neurons of the striatum in MPTP-treated monkeys and Parkinson's disease: An in situ hybridization study of GAD67-mRNA","volume":"7","author":"Levy","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1006\/nbdi.2000.0375_RF23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/exnr.1994.1007","article-title":"On the role of enkephalin cotransmission in the GABAergic striatal efferents to the Globus Pallidus","volume":"125","author":"Maneuf","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.2000.0375_RF24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0306-4522(89)90120-6","article-title":"Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"32","author":"Mitchell","year":"1989","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2000.0375_RF25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1471-4159.1999.0720682.x","article-title":"Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D-1 or D-2 receptor agonists","volume":"72","author":"Morissette","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2000.0375_RF26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0306-4522(94)00606-6","article-title":"Preproenkephalin and preprotatachykinin messenger RNA expression in normal basal ganglia and in Parkinson's disease","volume":"66","author":"Nisbet","year":"1995","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2000.0375_RF27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0306-4522(94)90272-0","article-title":"Temporal dissociation between changes in striatal enkephalin and substance P messenger RNAs following striatal dopamine depletion","volume":"60","author":"Nisenbaum","year":"1994","journal-title":"Neuroscience"},{"key":"10.1006\/nbdi.2000.0375_RF28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1523\/JNEUROSCI.10-03-00860.1990","article-title":"Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP","volume":"10","author":"Palombo","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2000.0375_RF29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","article-title":"Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res. Rev."},{"key":"10.1006\/nbdi.2000.0375_RF30","first-page":"506","article-title":"Impaired activation of frontal areas during movement in Parkinson's disease: A PET study","volume":"60","author":"Playford","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1006\/nbdi.2000.0375_RF31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/brain\/121.3.527","article-title":"Cortical motor overactivation in parkinsonian patients with l-dopa-induced peak-dose dyskinesia","volume":"121","author":"Rascol","year":"1998","journal-title":"Brain"},{"key":"10.1006\/nbdi.2000.0375_RF32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archneur.1992.00530260044017","article-title":"Supplementary and primary sensory motor area activity in Parkinson's disease: Regional cerebral blood flow changes during finger movements and effects of apomorphine","volume":"49","author":"Rascol","year":"1992","journal-title":"Arch. Neurol."},{"key":"10.1006\/nbdi.2000.0375_RF33","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1073\/pnas.89.20.9954","article-title":"Paradoxical increases in striatal neuropeptide gene expression following ischemic lesion of the cerebral cortex","volume":"89","author":"Salin","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2000.0375_RF34","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1523\/JNEUROSCI.19-15-06643.1999","article-title":"Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys: Implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatolology","volume":"19","author":"Schneider","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2000.0375_RF35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0006-8993(88)91603-4","article-title":"Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: Dependence on sodium but not calcium ions","volume":"443","author":"Sirinathsinghji","year":"1988","journal-title":"Brain Res."},{"key":"10.1006\/nbdi.2000.0375_RF36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1098-2396(199710)27:2<122::AID-SYN3>3.0.CO;2-G","article-title":"Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of parkinsonian monkeys","volume":"27","author":"Soghomonian","year":"1997","journal-title":"Synapse"},{"key":"10.1006\/nbdi.2000.0375_RF37","series-title":"Toxin-Induced Models of Neurological Disorders","first-page":"139","article-title":"Behavioral effects of MPTP administration in the Vervet monkey, a primate model of Parkinson's disease","author":"Taylor","year":"1994"},{"key":"10.1006\/nbdi.2000.0375_RF38","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1523\/JNEUROSCI.08-12-04755.1988","article-title":"Differential expression of preproenkephalin and preprodynorphin mRNAs in striatal neurons: High levels of preproenkephalin expression depend on cerebral cortical afferents","volume":"8","author":"Uhl","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.2000.0375_RF39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1523\/JNEUROSCI.17-02-00765.1997","article-title":"Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: An in situ hybridization study of cytochrome oxidase subunit I mRNA","volume":"17","author":"Vila","year":"1997","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996100903759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996100903759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T02:56:34Z","timestamp":1576551394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996100903759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["S0969996100903759"],"URL":"https:\/\/doi.org\/10.1006\/nbdi.2000.0375","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}